» Articles » PMID: 17704265

Subtypes of the Plasmid-encoded Serine Protease EspP in Shiga Toxin-producing Escherichia Coli: Distribution, Secretion, and Proteolytic Activity

Overview
Date 2007 Aug 21
PMID 17704265
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

We investigated the prevalence, distribution, and structure of espP in Shiga toxin-producing Escherichia coli (STEC) and assessed the secretion and proteolytic activity of the encoded autotransporter protein EspP (extracellular serine protease, plasmid encoded). espP was identified in 56 of 107 different STEC serotypes. Sequencing of a 3,747-bp region of the 3,900-bp espP gene distinguished four alleles (espPalpha, espPbeta, espPgamma, and espPdelta), with 99.9%, 99.2%, 95.3%, and 95.1% homology, respectively, to espP of E. coli O157:H7 strain EDL933. The espPbeta, espPgamma, and espPdelta genes contained unique insertions and/or clustered point mutations that enabled allele-specific PCRs; these demonstrated the presence of espPalpha, espPbeta, espPgamma, and espPdelta in STEC isolates belonging to 17, 16, 15, and 8 serotypes, respectively. Among four subtypes of EspP encoded by these alleles, EspPalpha (produced by enterohemorrhagic E. coli [EHEC] O157:H7 and the major non-O157 EHEC serotypes) and EspPgamma cleaved pepsin A, human coagulation factor V, and an oligopeptide alanine-alanine-proline-leucine-para-nitroaniline, whereas EspPbeta and EspPdelta either were not secreted or were proteolytically inactive. The lack of proteolysis correlated with point mutations near the active serine protease site. We conclude that espP is widely distributed among STEC strains and displays genetic heterogeneity, which can be used for subtyping and which affects EspP activity. The presence of proteolytically active EspP in EHEC serogroups O157, O26, O111, and O145, which are bona fide human pathogens, suggests that EspP might play a role as an EHEC virulence factor.

Citing Articles

Prevalence and Characteristics of Plasmid-Encoded Serine Protease EspP in Clinical Shiga Toxin-Producing Strains from Patients in Sweden.

Wang L, Hua Y, Bai X, Zhang J, Mernelius S, Chromek M Microorganisms. 2024; 12(3).

PMID: 38543640 PMC: 10975849. DOI: 10.3390/microorganisms12030589.


IgG Binds Serine Protease EspP and Protects Mice From O157:H7 Infection.

Tontanahal A, Sperandio V, Kovbasnjuk O, Loos S, Kristoffersson A, Karpman D Front Immunol. 2022; 13:807959.

PMID: 35250980 PMC: 8894809. DOI: 10.3389/fimmu.2022.807959.


Serine Protease Autotransporters of the (SPATEs): Out and About and Chopping It Up.

Pokharel P, Habouria H, Bessaiah H, Dozois C Microorganisms. 2019; 7(12).

PMID: 31766493 PMC: 6956023. DOI: 10.3390/microorganisms7120594.


Enterohemorrhagic (EHEC)-Secreted Serine Protease EspP Stimulates Electrogenic Ion Transport in Human Colonoid Monolayers.

Tse C, In J, Yin J, Donowitz M, Doucet M, Foulke-Abel J Toxins (Basel). 2018; 10(9).

PMID: 30200426 PMC: 6162544. DOI: 10.3390/toxins10090351.


Variation in the Distribution of Putative Virulence and Colonization Factors in Shiga Toxin-Producing Isolated from Different Categories of Cattle.

Caceres M, Etcheverria A, Fernandez D, Rodriguez E, Padola N Front Cell Infect Microbiol. 2017; 7:147.

PMID: 28503491 PMC: 5408013. DOI: 10.3389/fcimb.2017.00147.


References
1.
Loveless B, Saier Jr M . A novel family of channel-forming, autotransporting, bacterial virulence factors. Mol Membr Biol. 1997; 14(3):113-23. DOI: 10.3109/09687689709048171. View

2.
Szabady R, Peterson J, Skillman K, Bernstein H . An unusual signal peptide facilitates late steps in the biogenesis of a bacterial autotransporter. Proc Natl Acad Sci U S A. 2004; 102(1):221-6. PMC: 544056. DOI: 10.1073/pnas.0406055102. View

3.
Mellmann A, Bielaszewska M, Zimmerhackl L, Prager R, Harmsen D, Tschape H . Enterohemorrhagic Escherichia coli in human infection: in vivo evolution of a bacterial pathogen. Clin Infect Dis. 2005; 41(6):785-92. DOI: 10.1086/432722. View

4.
Brooks J, Sowers E, Wells J, Greene K, Griffin P, Hoekstra R . Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002. J Infect Dis. 2005; 192(8):1422-9. DOI: 10.1086/466536. View

5.
Karch H, Tarr P, Bielaszewska M . Enterohaemorrhagic Escherichia coli in human medicine. Int J Med Microbiol. 2005; 295(6-7):405-18. DOI: 10.1016/j.ijmm.2005.06.009. View